Stanley B. Prusiner

Stanley B. Prusiner is an American neurologist and biochemist who revolutionized the understanding of infectious diseases through his discovery of prions. He proposed the radical prion hypothesis, which posits that certain neurodegenerative diseases are caused by misfolded proteins that can transmit their abnormal shape to normal variants of the same protein. For this groundbreaking work, he was awarded the Nobel Prize in Physiology or Medicine in 1997. His career has been primarily based at the University of California, San Francisco, where he has directed the Institute for Neurodegenerative Diseases.

Early life and education

Stanley Ben Prusiner was born in Des Moines, Iowa, and raised in the Midwestern United States. He completed his undergraduate education at the University of Pennsylvania, where he studied chemistry. He then earned his M.D. from the University of Pennsylvania School of Medicine in 1968. Following an internship at the UCSF Medical Center, he pursued postdoctoral training in biochemistry at the National Institutes of Health in Bethesda, Maryland. His early clinical experiences at the UCSF neurology service, where he encountered a patient with Creutzfeldt–Jakob disease, ignited his lifelong research interest in neurodegenerative disorders.

Prion hypothesis and research

In the 1970s, Prusiner began investigating the causative agent of scrapie, a fatal neurodegenerative disease in sheep, and its human counterparts like Creutzfeldt–Jakob disease and kuru. Contrary to the prevailing scientific dogma that infectious agents required DNA or RNA, his experiments suggested the pathogen was a novel, proteinaceous infectious particle. In 1982, he coined the term "prion" (from *pro*teinaceous and *in*fectious) to describe this agent. His research, detailed in publications in the journal Science, demonstrated that prions could replicate by inducing normal cellular prion protein to misfold into a pathogenic, aggregated form. This work faced intense skepticism from the scientific community, including prominent researchers like Laura Manuelidis of Yale University, but was ultimately validated.

Nobel Prize and scientific recognition

Prusiner's prion theory was formally recognized with the awarding of the Nobel Prize in Physiology or Medicine in 1997. The Nobel Assembly at the Karolinska Institute stated his discovery established a new biological principle of infection and had profound implications for understanding diseases like bovine spongiform encephalopathy (Mad cow disease). This accolade followed other major honors, including the prestigious Albert Lasker Award for Basic Medical Research in 1994 and the Wolf Prize in Medicine in 1996. The Nobel Prize solidified the acceptance of the prion concept within fields such as molecular biology, neurology, and pathology.

Later career and academic appointments

Following his Nobel Prize, Prusiner continued to lead a prolific research program. He holds faculty positions as a professor of neurology and biochemistry at the University of California, San Francisco and as a professor of biochemistry and biophysics at the University of California, Berkeley. He founded and serves as the director of the Institute for Neurodegenerative Diseases at UCSF. His later research has expanded to investigate the potential role of prion-like mechanisms in more common conditions such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis. He has also been involved in biotechnology ventures, co-founding companies like InPro Biotechnology.

Awards and honors

Throughout his career, Stanley B. Prusiner has received numerous national and international awards. In addition to the Nobel Prize, the Lasker Award, and the Wolf Prize, he has been honored with the Potamkin Prize from the American Academy of Neurology, the Richard Lounsbery Award from the National Academy of Sciences, and the Gairdner Foundation International Award. He is an elected member of several prestigious societies, including the United States National Academy of Sciences, the Institute of Medicine, and the American Academy of Arts and Sciences. He has also received honorary doctorates from institutions like the University of Chicago and the University of Basel.

Category:American biochemists Category:Nobel laureates in Physiology or Medicine Category:University of California, San Francisco faculty